|

To Evaluate the Clinical Efficacy of Probiotics in Patients with the Breast Cancer

RECRUITINGN/ASponsored by GenMont Biotech Incorporation
Actively Recruiting
PhaseN/A
SponsorGenMont Biotech Incorporation
Started2024-04-08
Est. completion2026-04-01
Eligibility
Age20 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06039644

Summary

Chemotherapy-associated side-effects would affect therapeutic effect, quality of life, and cause permanent harm to breast cancer patients. This study is designed to explore after consumption of probiotics of lactobacillus composite strain powder sachets for 6 months in breast cancer chemotherapy, and whether the improvement of meliorate the side effects, further assists patients completing the chemotherapy.

Eligibility

Age: 20 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Stage I-III breast patients using anthracycline-based and taxane-based chemotherapy (not limited before or after chemotherapy/surgery)
* BMI \> 18 kg/m\^2
* Age between 20 and 80 years old
* Patients judged by physicians to participate in this trial and who are willing

Exclusion Criteria:

* Pregnant or lactating female patients
* Patients with bariatric surgery, gastrointestinal resections, Crohn's disease, celiac disease
* BMI \< 18 kg/m\^2
* Patient who have severe allergy to soybeans or peanuts
* Those who are under 20 years old or over 80 years old

Conditions2

Breast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.